CRG
Menu Internet
English SelectedChange language to SpanishChange language to Latin American Spanish
Buscador_Home Buscador_Home
Search
 Neurobehavioral Phenotyping of Mouse Models of Disease
Group Leader:



1989 Ph.D. Department of Physiology and Pharmacology, Universidad de Cantabria (Spain).
1990-1993 Postdoctoral work at the Universidad Autňnoma de Barcelona (Spain).
1993-1997 Assistant Professor at the Universidad de Cantabria (Spain).
1997-2001 Research position. Medical and Molecular Genetics Center-Institut de Recerca Oncológica (IRO), Barcelona (Spain).
2001 Present Group Leader at the Center for Genomic Regulation, Barcelona (Spain).

Summary
The overall goal of our research is the understanding of the role of putative candidate genes for human complex genetic diseases that impair the structural elements connecting the neurons with consequences on brain cognitive systems. Using a wide variety of relevant behavioral paradigms, our laboratory is investigating specific links between cognitive impairments and memory disorders in patients with Down syndrome and behavioral deficits in mouse models of this disease. We are also currently working on candidate genes involved in dendrites/spine dysmorphology and altered neural plasticity in learning and memory brain circuits. Our second research line is directed to the study of panic disorder. We are interested in candidate genes that participate in the dysfunction of brain circuits involved in fear-related memories and in mouse behavioral traits relevant to panic and to anxiety.

Most of our work employs the use of transgenic and knockout mice for genes expressed in the brain, but we also obtain important information about the genetic basis of behavior performing inbred strain surveys and studying recombinant inbred strains. Our experimental approaches include behavioral analysis with multiple assessment tools that will detect basic alterations in nervous system function. Assessment targets are basic neurological function, brainstem-spinal cord reflex, motor function/control centers, exploratory activity, anxiety-related responses, depression, sensorimotor gating, social interactions, and learning and memory. We also use neurohistological and morphometric approaches to determine a structural correlation for the detected phenotypic traits and cellular/molecular biology techniques to get insight into the underlying mechanism.
 

Last modification: 17/10/2006


Research Lines
Other Activities
Selected Publications

Fillat C, Dierssen M, Martínez de Lagrán M, Altafaj X.
"Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome"
CNS & Neurolog Disord-Drug Targets 9(4):429-38 (2010).
Santos M, Summavielle T, Teixeira-Castro A, Silva-Fernandes A, Duarte-Silva S, Marques F, Martins L, Dierssen M, Oliveira P, Sousa N, Maciel P..
"Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the/ involvement of the cerebral cortex in early stages of Rett syndrome."
Neuroscience [Epub ahead of print] (2010).
Azkona G, Levannon D, Groner Y, Dierssen M..
"In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural/ characterization of a double transgenic mouse model."
Amino Acids [Epub ahead of print] (2010).
Toiber D, Azkona G, Ben-Ari S, Torán N, Soreq H, Dierssen M..
"Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations."
Neurobiol Dis. [Epub ahead of print] (2010).
Lott IT, Dierssen M..
"Cognitive deficits and associated neurological complications in individuals with Down's syndrome."
Lancet Neurol 9(6):623-33 (2010).

Other information about the group

We acknowledge the financial contribution of the Spanish Ministry of Science and Technology and the European Regional Development Fund (ERDF) to the development of the project “Behavioral and pharmacological characterization of murine models with overexpression of NTRK3 in panic and anxiety disorders" (ref. SAF2001-1231).




Group Members


Neurobehavioral Phenotyping of Mouse Models of Disease